Direkt zum Inhalt
Merck
  • Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.

Age-related changes of hepatic clearances of cytochrome P450 probes, midazolam and R-/S-warfarin in combination with caffeine, omeprazole and metoprolol in cynomolgus monkeys using in vitro-in vivo correlation.

Xenobiotica; the fate of foreign compounds in biological systems (2014-11-05)
Takashi Koyanagi, Yasuharu Nakanishi, Norie Murayama, Yoshiyuki Yamaura, Kanami Ikeda, Koji Yano, Shotaro Uehara, Masahiro Utoh, Soonih Kim, Yasuhiro Uno, Hiroshi Yamazaki
ZUSAMMENFASSUNG

1. Pharmacokinetics of human cytochrome P450 probes (caffeine, racemic warfarin, omeprazole, metoprolol and midazolam) were investigated after single intravenous and oral administrations at doses of 0.20 and 1.0 mg kg(-1), respectively, in combination to three young (3-year-old) and three aged (16-year-old) cynomolgus monkeys. 2. The plasma concentrations of caffeine and R-/S-warfarin decreased slowly in a monophasic manner, but those of omeprazole, metoprolol and midazolam decreased rapidly, in a similar manner to those as reported for pharmacokinetics in humans. 3. The mean maximum concentrations of R- and S-warfarin (4.6 and 3.7 µg/mL, respectively) in aged monkeys after oral administration were significantly higher than those in young monkeys (3.3 and 2.7 µg/mL). The mean clearance (CL) values of midazolam in aged monkeys (9.5 mL/min/kg) were significantly lower than those in young monkeys (13 mL/min/kg). 4. Individual intrinsic CL values for omeprazole (r = 0.29) and metoprolol (r = 0.30) of individual monkey livers were inversely correlated with their ages significantly (p < 0.05) in liver microsomes prepared from 55 cynomolgus monkeys. 5. These results suggest that cynomolgus monkeys could be a good model for humans, especially with particular characteristics in reduced CLs of some human P450 substrates by aging.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Koffein, anhydrous, 99%, FCC, FG
Sigma-Aldrich
Theophyllin, anhydrous, ≥99%, powder
Sigma-Aldrich
Koffein, powder, ReagentPlus®
Sigma-Aldrich
Theobromin, ≥98.0%
Supelco
Koffein, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Koffein, United States Pharmacopeia (USP) Reference Standard
USP
Koffein-Schmelzpunkt-Standard, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Omeprazol, solid
USP
Omeprazol, United States Pharmacopeia (USP) Reference Standard
Supelco
Coffein Schmelzpunktstandard, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Omeprazol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
1,7-Dimethylxanthin, ~98%, solid
USP
Warfarin, United States Pharmacopeia (USP) Reference Standard
Supelco
Koffein, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
Warfarin, PESTANAL®, analytical standard
Sigma-Aldrich
Koffein, Sigma Reference Standard, vial of 250 mg
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
USP
Theophyllin, United States Pharmacopeia (USP) Reference Standard
Supelco
Theophyllin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Koffein, anhydrous, tested according to Ph. Eur.
Supelco
Mettler Toledo Calibration Substance ME 18872, Caffeine, traceable to primary standards (LGC)
Supelco
Warfarin, analytical standard
Sigma-Aldrich
Koffein, meets USP testing specifications, anhydrous
Supelco
Theobromin, analytical standard
Sigma-Aldrich
β-D-Allose, rare aldohexose sugar
Sigma-Aldrich
Koffein, BioXtra
Koffein, European Pharmacopoeia (EP) Reference Standard
Koffein für die Systemeignung, European Pharmacopoeia (EP) Reference Standard
Theophyllin, European Pharmacopoeia (EP) Reference Standard
Supelco
Omeprazol, analytical standard